curve lines
Customer Success Story

Strengthening radiopharmacy research and clinical production with Synthera®+ Platform

Synthera+ Platform

UZ Gent needed a reliable in-house radiotracer production solution, ensuring continuity from research to clinical use.

To address their needs, the UZ Gent hospital selected IBA and its Synthera®+ Platform. The hospital was looking for a solution combining reliability, regulatory compliance, and flexibility for evolving scientific requirements.


The hospital adopted a complete Synthera® configuration, including three synthesis modules, an IFP™ automated cassette loader, an HPLC and an extension module. This set up is used daily for the production of fluorodeoxyglucose (FDG) and other fluorine-18 labelled radiopharmaceuticals.


The Synthera®+ Platform supports radiopharmacy activities across the entire value chain, from tracer research and development to routine clinical production.

A long-term partnership with IBA enabled seamless integration of the Synthera® + Platform into UZ Gent’s radiopharmacy workflow.

Through close collaboration, IBA supported the UZ Gent in integrating the Synthera®+ Platform into daily radiopharmacy operations and optimizing production workflows. This partnership ensured efficient use of the equipment for both routine clinical production and research.


By combining technical expertise with hands-on support, IBA helped UZ Gent maximize the performance and flexibility of the Synthera®+ Platform while maintaining high standards of reliability, safety and regulatory compliance.

curve lines

Our journey together

Universitair Ziekenhuis Gent – UZ Gent

  • Step 1
    Equipment 
    preparation 

  • Step 2
    Installation

  • Step 3
    Site acceptance
    and testing

  • Step 4
    Training

    Step 5
    Maintenance
    and services

  • Phase 1

    Project conception
    The production scope was defined collaboratively. The module installation was planned to meet laboratory needs while ensuring compliance with Good Manufacturing Practices and all relevant safety standards.

  • Phase 2

    Equipment integration
    The chemistry module was installed, connected, and configured. All components were carefully checked to ensure proper operation. 

  • Phase 3

    Validation & operation
    Synthesis protocols and production processes were validated in accordance with quality standards, enabling safe, compliant and reliable routine operations. 

  • Phase 4

    Optimization & longevity
    Maintenance keeps the equipment reliable and up to date. Training supports safe and efficient system operation and long-term performance. 

Synthera+ Platform

The Synthera®+ Platform boosted UZ Gent’s tracer production while supporting research and innovation.

With the Synthera®+ Platform, UZ Gent successfully produced more than 1.000 batches of fluorodeoxyglucose to date, all fully compliant with the European Pharmacopoeia monograph.
 

It highlights the value of an integrated, end-to-end chemistry platform. The solution ensures operational reliability, supports high-quality production, and offers scalability for future research needs, while maintaining high patient care standards.

Quote illustration image
Jan Courtuyn Synthera
Jan Courtyn
Nuclear Site Manager
UZ Gent, Belgium

The Synthera®+ Platform supports reliable radiopharmaceutical production and research through a long-term partnership with IBA.

"The Synthera®+ Platform is a key element of our radiopharmacy operations at UZ Gent. Its reliability and performance support the routine production of fluorodeoxyglucose (FDG), and other fluorine-18 labelled radiopharmaceuticals for clinical use and study.

 

The multi-run capability enabled by the automated cassette loader allows us to optimize laboratory capacity and support efficient daily production. At the same time, the flexibility of the Synthera®+ chemistry modules supports our research activities and the development of new tracers and fluorine-18 labelling techniques.

 

Our long-standing collaboration with IBA is built on trust and technical expertise. This close partnership ensures that the Synthera®+ Platform continues to meet our operational and research requirements over time."

curve lines
Quote illustration image
Sujala Vaniyath
Sujala Vaniyath
Sales Manager
IBA RadioPharma Solutions, Belgium

Thanks to the Synthera®+ Platform, UZ Gent has a robust chemistry set up to produce radiotracers reliably and advance research.

"IBA is proud to support UZ Gent with the Synthera®+ Platform, enabling reliable and high-quality radiotracers production while supporting ongoing research and innovation. This long-term partnership illustrates how IBA solutions help hospitals deliver excellent patient care and advance scientific research."

Discover our radiochemistry modules

IBA, your trusted partner in radiochemistry